Cargando…
Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis
Group 2 innate lymphoid cells (ILCs) are thought to contribute to the pathogenesis of atopic dermatitis (AD). IL-4 stimulates T helper type 2 (Th2) cells and ILC2s to proliferate and produce cytokines. Dupilumab, an antibody against the IL-4 receptor, is used in AD therapy. We speculated that its ef...
Autores principales: | Imai, Yasutomo, Kusakabe, Minori, Nagai, Makoto, Yasuda, Koubun, Yamanishi, Kiyofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659712/ https://www.ncbi.nlm.nih.gov/pubmed/34909707 http://dx.doi.org/10.1016/j.xjidi.2021.100003 |
Ejemplares similares
-
Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
por: Nakatani-Kusakabe, Minori, et al.
Publicado: (2021) -
Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis
por: Miyamoto, Shoko, et al.
Publicado: (2023) -
Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice
por: Imai, Yasutomo, et al.
Publicado: (2017) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022) -
40 Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis
por: Imai, Yasutomo, et al.
Publicado: (2012)